Cytology recommended every 3 years from age 21; different screening options from age 30 to 65.
Use of primary HPV testing results in significantly lower odds of CIN3 compared with cytology testing
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
The major change includes screening with hrHPV testing alone as an alternative to cytology screening alone starting at age 30 years.
One clinician took issue with the image published in a January 2016 Clinical Advisor article.
College-aged students may benefit from continued education regarding the spread of HPV, especially oral transmission
Contaminated water leads to high rates of birth defects, thyroid cancer, and spontaneous abortions.
Confusion surrounds the current screening recommendations and guidelines.
The ACOG issued new guidelines for cervical cancer screening, recommending that screening start at age 21.
ACOG's current recommendations regarding Pap smear testing for cervical cancer may be the best evidence-based practice for patients.
The CDC reports that screening rates for colorectal, breast, and cervical cancer have dropped in recent years.
CDC notes that more than half of cervical cancer cases occur among women never or rarely screened
Two doses of quadrivalent HPV vaccine, rather than the recommended three, still protective.
Women previously treated for cervical intraepithelial neoplasia grade 3 have long-term elevated risk of invasive cancer and mortality.
HPV vaccination is widely offered but underused, and many continue annual Paps.